<scp>SET</scp> alpha and <scp>SET</scp> beta <scp>mRNA</scp> isoforms in chronic lymphocytic leukaemia

Danielle M. Brander(Duke University), J. Brice Weinberg(United States Department of Veterans Affairs), Kouros Owzar(Duke University), Daphne R. Friedman(Duke Medical Center), Thomas J. Kipps(University of California San Diego), C DAVIS, Eross Guadalupe(Duke Medical Center), Xi Wang(European Molecular Biology Organization), Youwei Chen(Fudan University), Dale J. Christensen, Laura Z. Rassenti(University of California San Diego), Dadong Zhang(Duke Cancer Institute), Alicia D. Volkheimer(Durham VA Medical Center)
British Journal of Haematology
November 15, 2018
10.1111/bjh.15677
Cited by 18

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k